Surgical Associates of Neenah SC — Neenah, Wisconsin

Surgical Associates of Neenah SC is a clinical research site located in Neenah, Wisconsin, United States 54956.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Surgical Associates of Neenah SC has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage IA Breast Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Neenah

Browse all research sites in Wisconsin · View every site in Neenah

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Surgical Associates of Neenah SC?

Surgical Associates of Neenah SC has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Surgical Associates of Neenah SC conducted?

Surgical Associates of Neenah SC has 6 clinical trials on record, with 5 currently active. Their work covers Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage IA Breast Cancer.

Is Surgical Associates of Neenah SC accredited by Crixeo Clinical Trials?

Surgical Associates of Neenah SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Surgical Associates of Neenah SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.